Cardiology overview cardiomyopathy: Difference between revisions

	Cardiology Overview
Home
Acute Coronary Syndromes
Antiplatelets and antithrombins
Cardiomyopathy
Congenital heart disease
Electrophysiology
Heart failure
Hypertension
Imaging
Invasive cardiology
Pericardial disease
Peripheral arterial disease
Pharmacology
Pregnancy
Preoperative evaluation
Prevention
Pulmonary hypertension
Stable angina
Valvular heart disease
Venous thromboembolism

Revision as of 00:04, 4 November 2011

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Athletes should be screened using a family history of sudden death and a murmur on physical examination. Electrocardiograms and echocardiograms are not cost effective in this population.

The myosin binding proteins C genetic variant carries a good prognosis.
The presence of VT / VF carries the poorest prognosis. Outflow gradient is also related to prognosis.

@@ Line 10: / Line 10: @@
 ===Treatment===
-* Atrial fibrillation in the patient with HOCM should be managed with amiodarone
-* The medical management of the patient with hypertrophic cardiomyopathy involves minimizing diastolic dysfunction, reducing left ventricular outflow tract obstruction, optimizing [[heart failure]] management, maintaining [[normal sinus rhythm]], rate control and anticoagulation in the presence of [[atrial fibrillation]], and implantation of an [[automatic implantable cardiac defibrillator]] in those patients who survive [[sudden cardiac death]].
 ==References==